These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 20204293)

  • 1. Use of 18F-fluorodeoxyglucose positron emission tomography for diagnosis of uterine sarcomas.
    Nagamatsu A; Umesaki N; Li L; Tanaka T
    Oncol Rep; 2010 Apr; 23(4):1069-76. PubMed ID: 20204293
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 18F-FES and 18F-FDG PET for differential diagnosis and quantitative evaluation of mesenchymal uterine tumors: correlation with immunohistochemical analysis.
    Zhao Z; Yoshida Y; Kurokawa T; Kiyono Y; Mori T; Okazawa H
    J Nucl Med; 2013 Apr; 54(4):499-506. PubMed ID: 23471314
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlation of Glut-1 glucose transporter expression with.
    Higashi K; Ueda Y; Sakurai A; Wang XM; Xu L; Murakami M; Seki H; Oguchi M; Taki S; Nambu Y; Tonami H; Katsuda S; Yamamoto I
    Eur J Nucl Med; 2000 Dec; 27(12):1778-85. PubMed ID: 11189940
    [TBL] [Abstract][Full Text] [Related]  

  • 4. FDG uptake, GLUT-1 glucose transporter and cellularity in human pancreatic tumors.
    Higashi T; Tamaki N; Torizuka T; Nakamoto Y; Sakahara H; Kimura T; Honda T; Inokuma T; Katsushima S; Ohshio G; Imamura M; Konishi J
    J Nucl Med; 1998 Oct; 39(10):1727-35. PubMed ID: 9776278
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Whole-body positron emission tomography with 18F-fluorodeoxyglucose is an effective method to detect extra-pelvic recurrence in uterine sarcomas.
    Sung PL; Chen YJ; Liu RS; Shieh HJ; Wang PH; Yen MS; Wen KC; Shen SH; Lai CR; Yuan CC
    Eur J Gynaecol Oncol; 2008; 29(3):246-51. PubMed ID: 18592788
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 18F-FDG/18F-FES standardized uptake value ratio determined using PET predicts prognosis in uterine sarcoma.
    Yamamoto M; Tsujikawa T; Yamada S; Kurokawa T; Shinagawa A; Chino Y; Mori T; Kiyono Y; Okazawa H; Yoshida Y
    Oncotarget; 2017 Apr; 8(14):22581-22589. PubMed ID: 28186981
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glut-1 expression and enhanced glucose metabolism are associated with tumour grade in bone and soft tissue sarcomas: a prospective evaluation by [18F]fluorodeoxyglucose positron emission tomography.
    Tateishi U; Yamaguchi U; Seki K; Terauchi T; Arai Y; Hasegawa T
    Eur J Nucl Med Mol Imaging; 2006 Jun; 33(6):683-91. PubMed ID: 16506050
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnostic performance of fluorine-18-fluorodeoxyglucose positron emission tomography imaging in uterine sarcomas: systematic review and meta-analysis of the literature.
    Sadeghi R; Zakavi SR; Hasanzadeh M; Treglia G; Giovanella L; Kadkhodayan S
    Int J Gynecol Cancer; 2013 Oct; 23(8):1349-56. PubMed ID: 23945203
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Presurgical Identification of Uterine Smooth Muscle Malignancies through the Characteristic FDG Uptake Pattern on PET Scans.
    Ho KC; Dean Fang YH; Lin G; Ueng SH; Wu TI; Lai CH; Chueh HY; Chao A; Chang TC; Yen TC
    Contrast Media Mol Imaging; 2018; 2018():7890241. PubMed ID: 30018513
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 18F-fluorodeoxyglucose positron emission tomography/computed tomography and the relationship between fluorodeoxyglucose uptake and the expression of hypoxia-inducible factor-1α, glucose transporter-1 and vascular endothelial growth factor in thymic epithelial tumours.
    Toba H; Kondo K; Sadohara Y; Otsuka H; Morimoto M; Kajiura K; Nakagawa Y; Yoshida M; Kawakami Y; Takizawa H; Kenzaki K; Sakiyama S; Bando Y; Tangoku A
    Eur J Cardiothorac Surg; 2013 Aug; 44(2):e105-12. PubMed ID: 23674658
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical value of [18-F]] fluorodeoxyglucose positron emission tomography imaging in soft tissue sarcomas.
    Schwarzbach MH; Dimitrakopoulou-Strauss A; Willeke F; Hinz U; Strauss LG; Zhang YM; Mechtersheimer G; Attigah N; Lehnert T; Herfarth C
    Ann Surg; 2000 Mar; 231(3):380-6. PubMed ID: 10714631
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of glucose transporters in human pancreatic tumors compared with increased FDG accumulation in PET study.
    Higashi T; Tamaki N; Honda T; Torizuka T; Kimura T; Inokuma T; Ohshio G; Hosotani R; Imamura M; Konishi J
    J Nucl Med; 1997 Sep; 38(9):1337-44. PubMed ID: 9293783
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Positron emission tomography with (18)F-fluorodeoxyglucose of uterine sarcoma: a comparison with magnetic resonance imaging and power Doppler imaging.
    Umesaki N; Tanaka T; Miyama M; Kawamura N; Ogita S; Kawabe J; Okamura T; Koyama K; Ochi H
    Gynecol Oncol; 2001 Mar; 80(3):372-7. PubMed ID: 11263934
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Positron emission tomography with 18F-fluorodeoxyglucose in patients with uterine sarcoma].
    Rebollo Aguirre AC; Ramos Font C; Bellón Guardia ME; Cabello García D; Gallego Peinado M; Rodríguez Fernández A; Llamas Elvira JM
    Rev Esp Med Nucl; 2007; 26(4):189-95. PubMed ID: 17662185
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Additional value of 16α-[18F]fluoro-17β-oestradiol PET for differential diagnosis between uterine sarcoma and leiomyoma in patients with positive or equivocal findings on [18F]fluorodeoxyglucose PET.
    Yoshida Y; Kiyono Y; Tsujikawa T; Kurokawa T; Okazawa H; Kotsuji F
    Eur J Nucl Med Mol Imaging; 2011 Oct; 38(10):1824-31. PubMed ID: 21656049
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Spectrum of FDG PET/CT findings of uterine tumors.
    Kitajima K; Murakami K; Kaji Y; Sugimura K
    AJR Am J Roentgenol; 2010 Sep; 195(3):737-43. PubMed ID: 20729454
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Standardized uptake values of uterine leiomyoma with 18F-FDG PET/CT: variation with age, size, degeneration, and contrast enhancement on MRI.
    Kitajima K; Murakami K; Yamasaki E; Kaji Y; Sugimura K
    Ann Nucl Med; 2008 Jul; 22(6):505-12. PubMed ID: 18670857
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantitative dynamic ¹⁸FDG-PET and tracer kinetic analysis of soft tissue sarcomas.
    Rusten E; Rødal J; Revheim ME; Skretting A; Bruland OS; Malinen E
    Acta Oncol; 2013 Aug; 52(6):1160-7. PubMed ID: 23198721
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Meta-Analysis of the Diagnostic Accuracy of Primary Bone and Soft Tissue Sarcomas by 18F-FDG-PET.
    Younis MH; Abu-Hijleh HA; Aldahamsheh OO; Abualruz A; Thalib L
    Med Princ Pract; 2020; 29(5):465-472. PubMed ID: 31887730
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correlation between in vivo 18F-FDG PET and immunohistochemical markers of glucose uptake and metabolism in pheochromocytoma and paraganglioma.
    van Berkel A; Rao JU; Kusters B; Demir T; Visser E; Mensenkamp AR; van der Laak JA; Oosterwijk E; Lenders JW; Sweep FC; Wevers RA; Hermus AR; Langenhuijsen JF; Kunst DP; Pacak K; Gotthardt M; Timmers HJ
    J Nucl Med; 2014 Aug; 55(8):1253-9. PubMed ID: 24925884
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.